Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic

[1]  A. Karch,et al.  Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease , 2015, Molecular Neurobiology.

[2]  Lucas G. Patrocinio,et al.  A 10-Year Review , 2015 .

[3]  A. Karch,et al.  Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases , 2014, Molecular Neurobiology.

[4]  I. Zerr,et al.  Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases , 2014, Neurobiology of Aging.

[5]  I. Zerr,et al.  Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay , 2013, PloS one.

[6]  A. Aguzzi,et al.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years , 2012, Brain : a journal of neurology.

[7]  A. Bizzi,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.

[8]  Mary Andrews,et al.  Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease , 2012, Annals of neurology.

[9]  A. Bizzi,et al.  Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.

[10]  M. Foote,et al.  14-3-3 proteins in neurological disorders. , 2012, International journal of biochemistry and molecular biology.

[11]  C. D'Giano,et al.  Creutzfeldt-Jakob Disease Surveillance in Argentina, 1997–2008 , 2011, Neuroepidemiology.

[12]  G. Jansen,et al.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study , 2011, BMC neurology.

[13]  K. Satoh,et al.  High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease , 2011, BMC neurology.

[14]  Steven J Collins,et al.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.

[15]  A. Green,et al.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  D. Varges,et al.  Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt–Jakob disease , 2010, The European journal of neuroscience.

[17]  H. Kretzschmar,et al.  14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes , 2009, Neurobiology of Aging.

[18]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[19]  I. Santana,et al.  Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients , 2009, Journal of Neurology.

[20]  J. Berger.  Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt–Jakob disease , 2008 .

[21]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[22]  M. Sierra-Moros,et al.  Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD , 2006, BMC neurology.

[23]  F. Maquart,et al.  Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice , 2005, Clinical chemistry and laboratory medicine.

[24]  P. Scheltens,et al.  Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice. , 2005, Clinical chemistry.

[25]  R. Castellani,et al.  Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease , 2004, Neurology.

[26]  J. Martín,et al.  A prospective study of CSF markers in 250 patients with possible Creutzfeldt–Jakob disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[27]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[28]  D. Zamir,et al.  HUMAN TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES , 1998 .

[29]  A. Green.  Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. , 2001, Biochemical Society transactions.

[30]  M. V. van Hemert,et al.  14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  J. Ironside,et al.  Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[32]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[33]  C. Gibbs,et al.  An enzyme‐linked immunosorbent assay to quantify 14‐3‐3 proteins in the cerebrospinal fluid of suspected Creutzfeldt‐Jakob disease patients , 2000, Annals of neurology.

[34]  F. Baas,et al.  14-3-3 testing in diagnosing Creutzfeldt–Jakob disease , 2000, Neurology.

[35]  C. McLean,et al.  Creutzfeldt-Jakob disease: diagnostic utility of 14–3–3 protein immunodetection in cerebrospinal fluid , 2000, Journal of Clinical Neuroscience.

[36]  L. Lannfelt,et al.  Quantification of Alzheimer Amyloid Peptides Ending at Residues 40 and 42 by Novel ELISA Systems , 1999 .

[37]  K. Blennow,et al.  Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[38]  J. Laplanche,et al.  14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[39]  O. Gefeller,et al.  Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[40]  Ronald L. Davis,et al.  Leonardo, a Drosophila 14-3-3 Protein Involved in Learning, Regulates Presynaptic Function , 1997, Neuron.

[41]  I. Zerr,et al.  The 14-3-3 brain protein and transmissible spongiform encephalopathy. , 1997, The New England journal of medicine.

[42]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[43]  H. Kretzschmar,et al.  Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease , 1995, The Lancet.

[44]  Jan Six,et al.  Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay , 1993 .